Abivax ABVX
NASDAQ ABVX
$96.85 +5.79 (+6.36%)
At close: Sep 28, 2026 · 4:00 PM EDT

Abivax (ABVX) Other Accumulated Expenses (2024 - 2025)

Updated

Abivax's Other Accumulated Expenses came in at $71.82 million for Q4 2025, up 36.9% from $52.47 million a year earlier.

Analysis

Abivax (ABVX) Other Accumulated Expenses (2024 - 2025) Analysis & Trends

At the end of FY2025, Abivax's Other Accumulated Expenses was $69.71 million, up 31.2% from FY2024.

  • Going back by year, Other Accumulated Expenses was $53.14 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 Abivax 7.15 Bn 7.15 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 71.82 Mn
Jun 30, 2025 39,618.59
Mar 31, 2025 -61,009.30
Dec 31, 2024 52.47 Mn
Sep 30, 2024 -80,170.02
Jun 30, 2024 -61,382.59
API Access

Abivax Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ABVX&period=max&api_key=YOUR_API_KEY